LINC02202

Across TCGA pan-cancer cohorts, LINC02202 RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of LINC02202’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC02202 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02202 is over-expressed in tumor, although a few such as BLCA and KICH show the opposite, repressed pattern.

BLCA, KICH, and THCA are the cancer types where LINC02202 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02202 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	III,IV	−1.585	<.001	11	view →
KICH	Female	All	−0.989	<.001	11	view →
THCA	All	IV	−0.695	<.001	11	view →
LUAD	Female	III,IV	−0.518	<.001	9	view →
LUSC	All	III,IV	−0.689	<.001	8	view →
LIHC	All	All	+0.257	<.001	8	view →
BRCA	All	II,III,IV	−1.765	<.001	6	view →
UCEC	All	All	−0.998	<.001	6	view →
KIRC	All	All	+0.345	<.001	6	view →
KIRP	Male	All	−0.546	<.001	5	view →
HNSC	Male	All	−0.264	.004	4	view →
HNSC	Female	IV	+0.320	.028	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

LINC02202–BLCA

Open the BLCA breakdown →